English Hb9210 PDF
English Hb9210 PDF
English Hb9210 PDF
Operator’s Manual
IVD. FOR IN VITRO DIAGNOSTIC USE ONLY
CAUTION: Before using the Premier Hb9210TM, please become familiar with all the
instructions in this manual.
Serial Number
_________________________________________
Proprietary Information
Software programs are protected by copyright. All rights are reserved. This software was
developed solely for use with intended equipment and for “in vitro” diagnostic applications as
specified in the operating instructions. All operating instructions must be followed. Copying or
other reproduction of the program is prohibited without the prior written consent of Trinity
Biotech.
Applications for Assay of variant haemoglobins, glycated haemoglobins and other proteins are
covered by one or more of the following US Patents:
5,843,788 5,719,053 6,020,203 5,801,053 9,164,115
Copyright © 2017
Contact addresses:
Support:
US/Canada/Puerto Rico Customers: Trinity Biotech USA 2823 Girts Road Jamestown, NY 14701 Tel:
1-800-325-3424 www.trinitybiotech.com [email protected]
International Customers: Trinity Biotech IDA Business Park Bray, Co. Wicklow, Ireland Tel: + 353 1 276 9898 Fax:
+ 353 1 276 9888 www.trinitybiotech.com [email protected]
1. Site Preparation
2. Introduction & System Description
3. Principles of Operation
4. Preparation for Operation
5. Hardware Components
6. Software & Operation
7. Results & Interpretation
8. Operator Maintenance
9. Operator Troubleshooting
10. Data Transmission
TLA Appendix
Expanded Table of Contents
Chapter 1: Site Preparation
1.1 Introduction 1 1.2 System Description 1 1.3 System Requirements 1 1.3.1 Environmental
Requirements 1 1.3.2 Electrical Requirements 1 1.4 Installation 2 1.4.1 Components Transport and
Storage Prior to Installation 2 1.4.2 Safe Lifting Technique 3 1.4.3 Instrument Installation Warnings 3 1.5
Important Symbols 4 1.6 Inspection 5 1.7 Important Safety Instructions 5
TLA Appendix
TLA 1 System Overview 1 TLA 2 System Operation 3 TLA 3 TLA LIS Protocol 9
PREMIER Hb9210TM Site
Preparation
CHAPTER CONTENTS
✓ System Requirements ✓ Installation ✓ Safety Precautions
Chapter 1 – Site Preparation
1.1 Introduction
This section defines environmental, physical and electrical requirements of the Premier Hb9210TM
HPLC instrument.
1.4 Installation
Installation of the Premier Hb9210TM HPLC instrument is performed only by authorized Trinity Biotech
representatives, for the most up-to-date installation instructions please contact Trinity Biotech or your
local distribution partner. Unauthorized installation may invalidate the instrument warranty.
1.4.1 Component Transport and Storage Prior to Installation
1. Components and system cabinet should be transported in their individual packing containers with
custom
foam inserts present.
2. Palletized entire system can only be stacked 1 unit high.
3. Follow all symbols on packaging, as shown in Figure 2 below.
4. Instrument components need to be shipped and stored in a relatively cool and dry location, 10 - 40°C
(50-
104°F) and 10 - 90% relative humidity (non-condensing).
2 | Chapter 1 – Site Preparation Rev. 23
The power line assigned to this instrument should not be shared with any other equipment due to potential
interference and power problems. To protect the operator, the instrument panels and cabinet must be
grounded. Verify the ground before installing the System.
1.4.2 Safe Lifting Technique
When lifting the Premier Hb9210TM instrument, it is important to practice safe lifting techniques. Safe
lifting instructions are as follows:
1. Stand close to the instrument component.
2. Bend your knees when lifting; do not use your back.
3. Let your legs do the lifting while keeping your back straight.
4. Practice team lifting (get somebody to help you) if necessary.
✓
x
Figure 1: Proper and Improper Lifting Technique
1.4.3 Instrument Installation Warnings
1. The system waste tubing needs to be checked for proper and correct drainage to a clearly marked
biohazard container or sanitary drain system. Incorrect drainage of the system solution(s) could result in a
biohazard to personnel.
2. Disposal of system waste must be in accordance with local regulations.
3 | Chapter 1 – Site Preparation Rev. 23
1.5 Important Symbols
1. 2. 3. 4. 5. 6.
7. 8. 9. 10. 11. 12.
13. 14. 15. 16. 17. 18.
Figure 2: Important Symbols
1. Biohazard 2. Grounding (Earth Grounding) 3. Grounding (Earth Grounding) 4. Warning: Surface Hot
5. Main Power On/Off 6. Transport with care 7. Components fragile 8. Do not get wet 9. Use no hooks
10. Do not expose components to strong magnetic fields 11. Box and components recyclable 12. Do not
stack more than “X” number of units high 13. This end up 14. Pinch point 15. Press/Crush point 16.
Dispose electrical components in accordance with
local regulations 17. Read Instructions Carefully Before Use 18. Device Interface Module
Figure 3 below shows other important symbols listed on the rear of the instrument.
Figure 3: Example of Rear Panel Label
4 | Chapter 1 – Site Preparation Rev. 23
1.6 Inspection
Inspect all cartons delivered. If you find signs of external damage, call Trinity Biotech. Do not unpack
cartons until your installation representative has arrived at your site.
CHA
PTER CONTENTS
Introduction & System
✓ Introduction ✓ Features ✓ Specifications Description
✓ Intended Use
Chapter 2 – Introduction & System Description
2.1 Introduction
The Premier Hb9210TM System consists of an integrated HPLC (2 Reagent Pumps, Injection Valve,
Oven and Detector), compact sample preparation system (Probe/Injection Port, Syringe Module and
Sample Transport) and the workstation (CPU and Touch Screen Interface) with the Premier Hb9210TM
Application Software.
Figure 1: The Premier Hb9210TM HPLC
The System consists of four main components used to fractionate and quantitate glycated haemoglobins:
1. The Premier Hb9210TM HPLC is composed of a dual high pressure pump system, column oven and
detector.
1 | Chapter 2 – Introduction & System Description Rev.23
2. The integrated autosampler/sample transport features a 210 sample capacity to start a single batch run
with the ability to continuously unload analyzed samples and load new samples. The additional STAT
sample capability allows for the analysis of an additional individual sample during batch analysis.
3. The system is interfaced to a personal computer for system control and data storage.
4. The Windows 7 or XPTM embedded software provides real-time chromatography and system
condition monitoring. Patient sample identification is automated during the sampling process via barcode
module in sample transport area. A barcode gun is supplied for hand-scanning of consumable barcodes,
package inserts, as well as easy inputting of Calibrator and Control material set points.
The fractionation and quantitation of glycated haemoglobin is accomplished using the principles of
boronate affinity high performance liquid chromatography.
2.2 Features
1. Full walk-away capability
2. Auto-verification of patient sample results
3. Windows 7 or XPTM embedded, touch screen, icon-driven, user-friendly software control
4. Small sample volume (0.5mL minimum haemolysate or mixed whole blood)
5. Ability to start a batch of up to 210 samples with the ability to continuously unload analyzed samples
and load
new samples
6. STAT sample capability
7. Automatic sampling and injection system
8. Integrated barcoding-while-sampling scanning of patient sample identification information
9. Individual sample reports with selectable units (mmol HbA1c/mol Hb (IFCC) & %HbA1c (NGSP)),
retention
times and area of peaks
10. Central processing unit (CPU) for automatic and unlimited storage of test results and archived test
results
11. Summary report of test results from each batch run – for on-screen review and/or printing
12. Ability to reprint batch summary reports and chromatograms from computer storage and archive
13. Real-time display allows monitoring of system operation
The software allows the operator to re-use the same sample rack during batch runs when running samples
without barcodes (identified as ‘noID’ samples in software). Please see Chapter 6, section 6.3.5 for more
details.
2 | Chapter 2 – Introduction & System Description Rev.23
2.3 Specifications
1. Sample Whole blood, haemolysates or packed red blood cells.1
2. Elements of Analysis HbA1c
3. Principle Boronate affinity high performance liquid chromatography (HPLC)
4. Minimum readable division Area percent = 0.01%
5. Minimum sample requirement ✓ 10μL (whole blood to make 1:150 haemolysate dilution,
0.5mL minimum haemolysate volume) ✓ 5μL (packed red blood cells to make 1:300 dilution, 0.5mL
minimum haemolysate volume) ✓ 0.5mL (mixed whole blood to make direct injection) 6. Sample
capacity 210 samples
7. Throughput 48 samples per hour
8. Analytical Column Boronate bonded to a porous polymer support gel
9. Column temperature 55.0oC ± 0.2oC
10. Autosampler Integrated 210 sample transport
11. Autoinjector Delivers sample volume with <1% error with 5-μL injection volume
12. Detection LED wavelength detector, 413 + 2nm
2.8 CE Mark
Trinity Biotech declares that the Premier Hb9210TM, related reagents and control materials conform to
the relevant provisions of the EX Council Directive 98/79/EC and Annex III, except Section 6, of the
IVDD as implemented by the European Union’s Medical Devices Regulations. The Global Medical
Device Nomenclature (GMDN) code is 30838.
4 | Chapter 2 – Introduction & System Description Rev.23
5 | Chapter 2 – Introduction & System Description Rev.23
PREMIER Hb9210TM
Principles of Operation
CHAPTER CONTENTS
✓ Principles of Analysis ✓ Merits of Assay ✓ Specific Performance ✓ Characteristics
Chapter 3 – Principles of Operation
3.1 Clinical Significance of HbA1c
Glycated haemoglobin (HbA1c) is of particular clinical interest in diabetes mellitus. Measurement of
glycated haemoglobin is a clinically useful means of assessing glycemic control in diabetics.6, 7 HbA1c
values reflect blood glucose levels over the circulatory half-life of the erythrocyte (about 60 days) and
correlate significantly with mean blood glucose levels during that time.4, 8 Therefore, measurement of
glycated haemoglobin provides a means, independent of multiple measurements such as patient records of
self-monitored blood glucose, for assessing the overall efficacy of therapy. Factors such as diet, exercise,
insulin regimen and stress can affect glycemic control, and therefore HbA1c values. In uncontrolled or
poorly-controlled diabetics, glycated haemoglobin values may be two or three times as high as in
non-diabetics, while meticulously controlled diabetics may have HbA1c values near or in the normal
range.9 Uncontrolled or poorly-controlled diabetics brought under better control will exhibit a gradual
drop in HbA1c values, reaching a new equilibrium in approximately eight weeks.1 There is significant
evidence that maintaining good glycemic control has a positive impact on the development of the
long-term complications of diabetes.10, 11, 12, 13, 14
7.2 Auto-Verification
The Premier Hb9210TM is designed with walk-away capability and does not require review of individual
reports – these features are defined as Auto-Verification.
The Auto-Verification feature of the Premier Hb9210TM is designed to assist with automatic review of
chromatography variables that an operator would normally check for, including:
✓ A stable re-equilibration baseline ✓ Acceptable peak area & valley heights ✓ Acceptable
pressure differences
✓ Acceptable retention times ✓ Acceptable Control/QC values
With multiple software checks in place, Auto Verification has been developed based on the following
platform benefits:
...Boronate Affinity Chemistry is a simplified separation method where only 2 peaks need to be
accurately quantified...
...a highly sensitive detector paired with advanced peak analysis software which gives an
accurate analysis of basic chromatogram quality...
Please note: the lab director has the responsibility to select and implement Auto-Verification rules and
processes that are appropriate for his or her lab. To use the Auto-Verification feature it is essential that
GLP recommendations are followed, specifically in regards to frequency of QC sample analysis. (see
Section 7.3 for QC recommendations)
7.2.1 Auto-Verification Features
There are two measures that must be followed if the Auto-Verification feature is to function in the manner
it was designed and in a manner in which it can be most effective to the laboratory.
1. Good (Clinical) Laboratory Practice (GLP/GCLP) QC guidelines are to be followed at all times.
2. Upon instrument installation, the Premier must be set-up by the laboratory administrator and the
appropriate
Trinity Biotech Technical Representative or Applications Specialist.
There are two measures that the Premier takes in order to ensure quality patient sample results.
Measure 1. Stable Baseline Confirmation
Each time a new column is installed on the instrument, a baseline calibration is run as part of the initial
calibration. The baseline ensures that any noise from the instrument is cancelled out and not interpreted as
part of final patient sample chromatography. Figure 1 below shows incorrect noise cancellation and how
it can be identified during the re-equilibration process.
Figure 1: Improper Cancellation of Baseline Noise from Final Chromatography
Noise from the pumps can be falsely interpreted by the detector as shifts in the chromatogram, and can
add unwanted peaks/area to the final result. The system will not allow the Operator to continue if:
1. A new column is installed – the system will not proceed to run the full System Calibration until a stable
baseline is detected.
2. During each patient sample analysis, four re-equilibration injections are performed to equilibrate the
column to analysis (in-run) conditions (temperature, flow, gradient). The fourth re-equilibration also
checks for baseline stability – it should be almost completely flat before injecting the first patient sample
in order to confirm and ensure that there is no unnecessary integration included in a final result
calculation.
2 | Chapter 7 – Results & Interpretation Rev. 23
Figure 2 provides an example of a baseline calibration. As emphasized by the noise circled on the screen,
it is not perfectly flat. Each baseline corresponds to a specific column. For this reason, an acceptable
baseline must be detected as part of the initial calibration each time a new column is installed. When the
Premier calibrates the baseline, it subtracts any noise from the system and will result in a flat and stable
baseline each time the re- equilibration injections are run.
Figure 2: Baseline Injection - Showing Typical System Noise
After a baseline is accepted, it results in a flat response from the detector when the re-equilibration
injections are run. In many cases, the first two re-equilibrations will exhibit some baseline noise, but this
is normal and due to the column conditioning itself for patient sample analysis.
The system has a built-in alert which checks the third and fourth re-equilibration for sufficient noise
cancellation. This means the following:
3 | Chapter 7 – Results & Interpretation Rev. 23
Four re-equilibration injections are run before any analysis cycle begins in order to ensure proper
conditions prior to reporting patient sample results.
✓ The system noise is being properly subtracted from any integration corresponding to the final patient
or QC
result ✓ The column is stable because the baseline has not shifted
In the event that the system does detect lingering system noise, or the baseline has shifted, the following
error message will appear and alert the user to re-run a baseline.
Figure 3: Baseline Limit Exceeded During 4th Re-Equilibration Alert Message
✓ An example of a flat fourth re-equilibration injection can be found in Figure 4.
Figure 4: Example of Flat Chromatogram Seen Upon Fourth Re-Equilibration
4 | Chapter 7 – Results & Interpretation Rev. 23
When viewing final chromatography, the original stored baseline can be seen as the green line on the
screen, while the actual detector response is seen in red.
Figure 5: Sample Run Showing Original Baseline in Green
Note in Figure 5 the original stored baseline in green and the final detector response in red. This green
trace is an indication of the system noise the Premier Hb9210TM is cancelling out to ensure optimal
analytical conditions.
5 | Chapter 7 – Results & Interpretation Rev. 23
Measure 2. Software Checks
The Premier Application Software has a feature entitled Peak Analysis & Results Codes which checks for
typical inconsistencies or irregularities in the final chromatography. This feature has been designed to
help the operator with interpretation of the chromatograms by ensuring that the correct result is being
generated. If any alarms are triggered, the system will provide an audible response which in turn alerts the
user that something has gone wrong. This feature is utilized with both patient sample runs and calibration
runs and has separate criteria for each scenario.
The Peak Analysis & Results Codes can be personalized to fit the QC policy of any laboratory, and
contain the following flexible preferences:
✓ Modifiable Results Codes can be adjusted within the manufacturer default ranges, not outside ✓
Frequency of occurrence before alert ✓ Whether or not to abort a run after ‘x’ amount of occurrences
The lab director has the ultimate responsibility to select and implement auto-verification rules and
processes that are appropriate for his or her lab.
The Peak Analysis & Results Codes for both Sample Run and Calibration Run are presented in Figure 6
& Figure 7 respectively, and are explained in-depth further on in the reading.
6 | Chapter 7 – Results & Interpretation Rev. 23
Although the Hb9210TM verification features in the Peak Analysis & Results Codes will sound an alarm
to alert the operator to any irregularities, it is still strongly recommended that the Operator reviews patient
results – even if baseline is stable & controls in-range.
Although the Peak Analysis & Results Codes are customizable, it is recommended that the manufacturer
defaults are only adjusted if advised to do so by a representative of Trinity Biotech or your local support
representative.
Figure 6: Peak Analysis & Results Codes - Patient Sample Runs
The different variables that the Samples Peak Analysis & Results Codes check for are defined as follows:
1. Total Peak Area – Measures the total area absorbed by the detector. 2. Height of Valley – Measures the
height of the valley between the two peaks. 3. Pressure Difference during Run (%) – Measures the
percentage pressure differences within a run. 4. Pressure during Analysis (bar) – Alerts the user of the
system exceeding the minimum or maximum allowable
pressure within a run. 5. First Peak Retention Times (minutes) – Alerts the operator of an
unacceptable first peak retention time. 6. Second Peak Retention Times (minutes) – Alerts the operator of
an unacceptable second peak retention
time. 7. Control I Result (range) – Alerts the operator of an unacceptable Control I result1. 8. Control
II Result (range) – Alerts the operator of an unacceptable Control I result1. 9. Value Result (linearity) –
Alerts the operator of a result detected by the system which falls out of the defined
range. 10. Not Within Normal Patient Range (user defined) – Flags low and high %HbA1c 11. Low
GHb Result (anaemic patients) – Flags a potentially anaemic patient.
1 The control range will shift based on the lot of QC material barcoded into the system.
7 | Chapter 7 – Results & Interpretation Rev. 23
Figure 7: Peak Analysis & Results Codes - Calibration Runs
The different variables that the Calibration Peak Analysis & Results Codes check for are defined as
follows:
1. Total Peak Area – Measures the total area absorbed by the detector. Area count limits are more
stringent for
Calibrator/QC materials. 2. Height of Valley – Measures the height of the valley between the two
peaks. 3. Pressure Difference during Run (%) – Measures the percentage pressure differences within a
run.. 4. Pressure during Analysis (bar) – Alerts the user of the system exceeding the minimum or
maximum
allowable pressure within a run. 5. First Peak Retention Times (minutes) – Alerts the operator of an
unacceptable first peak retention time. 6. Second Peak Retention Times (minutes) – Alerts the operator of
an unacceptable second peak retention
time. 7. Control I Result (range) – Alerts the operator of an unacceptable Control I result2. 8.
Control II Result (range) – Alerts the operator of an unacceptable Control II result2. 9. Does not apply to
Calibration Run 10. Does not apply to Calibration Run 11. Does not apply to Calibration Run 12.
Unacceptable Area Difference during Calibration (%) – Indicates significant differences in calibrator
values,
which would provide a poor calibration curve.
2 The control range will shift based on the lot of QC material barcoded into the system.
8 | Chapter 7 – Results & Interpretation Rev. 23
13. Calibration Slope Value – Ensures the calibration slope does not exceed a value of 2 – selecting the
checkbox will void calibrations which exceed this limit.
As is demonstrated in Figure 8 below, there are a number of points where key elements are confirmed by
the Peak Analysis & Results Codes in order for the chromatography to be considered acceptable. These
all help to assist the operator report the correct patient result. Also shown in green on the figure is the
system noise (e.g. from the reagent pumps) that is cancelled out of the final result.
Figure 8: Peak Analysis & Results Codes Points of Confirmation
7.2.2 Auto-Verification Features Conclusions
With multiple software checks in place paired with strict adherence to the QC recommendations made by
Trinity Biotech (based on GCLP & other key opinion leader recommendations), the feature is designed to
assist the operator with additional chromatography reviews. The software will alarm and alert the
Operator in case of any irregularities in the preset Peak Analysis & Results Codes parameters, which will
contribute to increased efficiency around the lab while maintaining confidence that the Premier will give a
precise and accurate result.
9 | Chapter 7 – Results & Interpretation Rev. 23
7.3 QC Recommendations
As part of good laboratory practices, operators should run controls and ensure values are within the ranges
stated on the package inserts. The Premier Hb9210TM allows for automated QC analysis at set intervals
in a batch, and Peak Analysis & Results Codes will alert operators if values fall outside of the stated
ranges. Frequently running QC samples assures the operator that the correct result is being generated. Of
the two Auto-Verification confirmations the system features, proper frequency of QC analysis is the most
important.
Trinity Biotech recommends that each level of control should be run at the beginning and end of each
analytical run, as defined by the laboratory, before reporting patient results.
Additionally, Trinity Biotech recommends that the chromatography from each QC/Control analysis be
reviewed by the operator for correctness prior to releasing patient results. The Auto-Verification features
have been designed to aid the Operator and help to reduce operator intervention. Auto-Verification acts as
a software-driven simulation of what an operator would normally check for in chromatography, however
it cannot fully replace a highly trained operator in regards to chromatography review and QC/Control
checks.
QC materials should be used in accordance with local, state, federal and accredited organizations. For
more information, please refer to your local guidelines for quality control regulations.
10 | Chapter 7 – Results & Interpretation Rev. 23
7.4 Report Interpretation
As mentioned, the system will generate 2 reports for each injection the system makes; a printed report &
an on- screen report for review. An example of the on-screen report is provided in Figure 9 while an
example of the printed report can be found in Figure 10.
7.4.1 On-Screen Report
The on-screen report is viewed on the Premier Touch-Screen Monitor each time any type of analysis is
carried out. The current sample being run is found on the top right of the window in real-time while
previous samples are shown on the larger main window for optional review.
Figure 9: On-Screen Report
7.4.2 Printed Report
The printed report can be generated in the PDF FactoryTM software featured in the Premier Application
Software or to a local/network printer. Figure 10 provides an example of a printed report.
11 | Chapter 7 – Results & Interpretation Rev. 23
Figure 10: Individual Report - Printout
7.4.3 Interpretation of Report
This section defines each element of the printed report (see Figure 10):
✓ “Batch xxx” indicates the batch number that has been assigned to the run by the computer. If the batch
is to
be reprinted, this number will be used to recall the batch from the hard drive.
✓ “Vial x:yyy” indicates which sample was injected. The “x” value tells which type of rack the sample
came from, W for Whole blood sample rack, H for Haemolysate sample rack and A for Anemic sample
rack. The “yyy” value tells which vial in the rack was injected.
✓ “abcdewxay” after the vial number is the patient ID. ID’s can be entered in three ways.
·
Automatically entered via the automated barcode reader
·
Key in names – the name will appear in the ID field.
·
Manually scan in Bar Code – the bar code will appear in the ID field.
12 | Chapter 7 – Results & Interpretation Rev. 23
✓ Date and Time the sample was injected.
✓ “Pressure = xx bar” – displays the pressure of the system at the point of injection. The “(xx to yy)”
numbers
show the extremes in the pressure readings during the sample run.
✓ Depending on reporting units selected, the values mMol HbA1c/mol Hb = yy, and/or HbA1c = x.x% –
are the
percentage of the glycated components in the sample.
✓ The chromatogram is a plot of the signal output from the detector. The first peak is the non-glycated
peak
and the second peak is the glycated peak.
✓ Retention time (RT) – the elapsed time between the start of the run and the apex of the peak.
✓ Total Area – the combined area of both peaks
✓ [FD4873564F865674] – this is a unique file identifier where the run data is stored.
✓ CONC = x.xx% is the area percent of the peak.
Two ‘Notches’
Reference ‘Notch’
3. Remove the column from the system and install a column bypass union (this is a metal zero dead
volume
union that was included with the tool kit)
4. In the Solvent Control dialog box set the flow to 100% A and 3.0 ml/min and press Set. This will allow
a
high reagent flow through the flow cell and may flush any air bubbles from the flow cell.
5. Allow this flow to pass through the flow cell for at least 5 minutes.
6. In the Application Software, select Devices and then Detector and select Zero analog output.
7. Then select Devices, Detector and select Acquire data.
8. The output from the detector will be monitored for 50-seconds and is represented with the horizontal
blue
line on the screen. The baseline should be flat.
9. If the baseline appears to be flat set the flow to zero and reinstall the column.
3
1
2
2 | TLA Appendix Rev. 22
TLA 2. System Operation
The sections below provide instructions on how to enable TLA connection, how to calibrate, run samples
and set the Control Scheme on the TLA Premier Hb9210TM.
Enable TLA System Connection
✓ From the Main Menu, select Edit → System
Parameters icon (see Figure 3).
Figure 3: System Parameters
✓ In the System Parameters window, ensure that ‘Enable connection of Inpeco TLA System’ is checked
(see Figure 4).
Figure 4: System Parameters Window
✓ LIS Communication parameters should be chosen based upon individual customer requirements (see
Figure 5).
Figure 5: LIS Communication
3 | TLA Appendix Rev. 22
TLA System Calibration
Prior to running a system calibration, the system must have completed steps 1 & 2:
1. Activation – see section 6.3.1
2. Baseline – see section 6.3.3
Then continue with the following steps:
3. Return to the Main Menu by touching or clicking the ‘Show User Interface’ button on the top left of the
main Premier Hb9210TM assay screen.
4. From the Main Menu screen, select the ‘Operation’ icon.
5. From the Operation Menu, select the ‘Run Calibration’ option shown below. This process includes a
baseline noise calibration to cancel out any system noise (e.g. Pumps, other vibrations) from the final
chromatography.
Figure 6: Operation Menu - Run Calibration Selection
The Calibration Run dialogue shown in Figure 7. NOTE: The 1x option has been disabled. Only the 2x
and 3x options are available (for improved calibration accuracy).
6. By selecting the Run Controls Only option, the system will simply run Control I, then Control II (and
not the calibrators).
7. Select the Run button, circled in Red in Figure 7. This will initiate the Calibration Run but the run will
not begin until the Calibrators and controls are placed on the TLA Carousel Wheel and the External TLA
button is pressed.
Figure 7: Run Calibration Confirmation Dialogue
4 | TLA Appendix Rev. 22
8. Press the External TLA button (Figure 2 Item 1). The button should turn solid red. This allows access
to the
Carousel Wheel.
9. The Internal TLA button located beside the Carousel Wheel will now light up solid blue (Figure 2 Item
2). Open
the Carousel Access Cover and load the Calibrators and Controls on the Carousel Wheel (Figure 2 Item
3).
10. Pressing the Internal TLA button will rotate the TLA Carousel Wheel one position at a time. The
Calibrators and
Controls should be placed on the wheel in the following order and locations:
✓ Position 1: Calibrator 1
✓ Position 2: Calibrator 2
✓ Position 3: Control I
✓ Position 4: Control II
Figure 8: Calibrator and Control Locations
11. Once the Calibrators and Controls are loaded, close the Carousel Access Cover.
12. Press the External TLA button. Once pressed, the button will flash yellow. It will then turn solid
yellow and the
Calibration will begin.
5 | TLA Appendix Rev. 22
When the Carousel Access Cover is opened, Position 1 will be first position presented. There are 10 positions in
total. The first 4 positions are for the Calibrators and Controls. The remaining 6 positions are for Priority Samples.
Pressing the Internal TLA button will move to the next position. When position 10 is reached, pressing the button
one more time will revert the wheel back to position 1.
Running Priority Samples
Prior to running Priority Samples, the system must be Activated and Calibrated.
1. From the Main Menu, select Operation then
select Priority Samples (see Figure 9).
Figure 9: Priority Samples
2. In the Priority Samples menu, check the required priority samples to run and press the Run icon. Figure
10
illustrates 3 priority samples to be run in positions 5, 6 and 7.
Figure 10: Priority Sample Run Menu
6 | TLA Appendix Rev. 22
There are 6 positions for Priority Samples. They are positions 5, 6, 7, 8, 9 and 10 on the Carousel Wheel. If the
system is currently processing samples from the track, and the Priority Sample Run button is pressed in the SW, the
system will finish the current sample and then go to stand by. It will then process all priority samples. All remaining
samples from the track will then be processed after the Priority Samples.
3. Press the External TLA button (Figure 2 Item 1). The button should turn solid red. This allows access
to the
Carousel Wheel (Figure 2 Item 3).
4. The Internal TLA button located beside the Carousel Wheel will now light up solid blue (Figure 2 Item
2). Open
the Carousel Access Cover and load the number Priority Samples that were selected in Figure 10.
5. Once the Priority Samples are loaded, close the Carousel Access Cover.
6. Press the External TLA button. Once pressed, the button will flash yellow. It will then turn solid yellow
and the
Priority Sample run will begin.
Accessing the TLA Carousel Wheel
The TLA Carousel Wheel can be accessed when the system is not running, to remove sample tubes, by
following the steps below:
1. Press the External TLA button (Figure 2 Item 1). The button should turn solid red. This allows access
to the
Carousel Wheel (Figure 2 Item 3).
2. The Internal TLA button located beside the Carousel Wheel will now light up solid blue (Figure 2 Item
2). Open
the Carousel Access Cover and remove the desired tubes.
Control Scheme
The Control Scheme can be customised to run Controls at specific intervals throughout a batch run. The
instructions below detail how to set the Control Scheme:
1. From the Main Menu, select Edit then select
Control Scheme icon (see Figure 11).
Figure 11: Control Scheme Icon
2. In the Control Scheme window, it is possible to:
✓ Alternate Control I & II every interval – selecting this option and setting the interval to 0, no controls
will run. By setting a desired interval number, Control I will run after the desired number of samples
followed by Control II at the next interval of samples. This pattern will repeat until the batch run
completes. See Figure 12.
✓ Run Control I & II every interval – selecting this option and setting the interval to 0, no controls will
run. By setting a desired interval number, Control I & II will run after the desired number of samples.
This pattern will repeat until the batch run completes. See Figure 12.
7 | TLA Appendix Rev. 22
Figure 12: Control Scheme Options
8 | TLA Appendix Rev. 22
TLA 3. TLA LIS Protocol
LIS Transmission (ASTM E1394)
Each patient set of results sent to the LIS will have:
✓ Header Record – only sent once at beginning of transmission. ✓ Patient Record ✓ Order Record ✓
Six Result Records ✓ Message Terminator Record – only sent once at end of transmission.
Header Record
The Header Record starts with the “H” character (ASCII 72) and is followed by the characters used for
the Field Delimiter, “|” (ASCII 124); Repeat Delimiter, “\” (ASCII 92); Component Delimiter, “^”
(ASCII 94) and the Escape Character, “&” (ASCII 38). This first series of 5 characters constitute the 1st
field of the Header Record and as all fields, is followed by the Field Delimiter, “|”. The rest of the Header
Record fields are explained below:
# Field Value or Use 1 Record type ID H|\^&
(Stands for Header record and consists of 5 characters) 2 Control ID Not used. 3 Access password Not
used. 4 Instrument
Identity
ID of instrument in the format: “PREMIER^XXXXXX” (Quotation marks are not sent.) Component 1,
PREMIER, is the instrument type; component 2, XXXXXX, is the instrument serial number. 5 Sender
name / ID Not used. 6 Sender address Not used. 7 Reserved Not used. 8 Sender telephone
#
Not used.
9 Sender
characteristics
Not used.
10 Receiver Identity ASTM RECVR 11 Receiver ID Not used. 12 Comment /
instructions
Not used.
13 Processing ID P
(stands for Production)
9 | TLA Appendix Rev. 22
14 Specification
version number
E 1394-97
15 Time stamp for message generation
Current date and time in the format: YYYYMMDDHHMMSS
As prescribed in the ASTM E1394-97 document that describes the protocol and fields of this usage, the
fields are separated with a defined Field Delimiter, “|”; empty or Not used fields will only contain the
Field Delimiter. The final field may or may not end with the Field Delimiter. The end of the Header
Record will be indicated with a Carriage Return character (ASCII 13). Any ASTM E1394-97 prescribed
fields following the Carriage Return character will not be used and therefore not sent.
Patient Record
The Patient Record is used with minimal information. In this situation, the Patient Record is used only to
signal that new patient results are forthcoming. The Patient Record fields are explained below:
# Field Value or Use 1 Record type ID P
(Stands for Patient type record) 2 Sequence number 1 through 7, then
repeats.
The fields are separated with a defined Field Delimiter, “|”. The final field may or may not end with the
Field Delimiter. The end of the Patient Record will be indicated with a Carriage Return character (ASCII
13). Any ASTM E1394-97 prescribed fields following the Carriage Return character will not be used and
therefore not sent.
Order Record
The Order Record is also used with minimal information, as the HbA1c software does not accept order or
assay commands from the LIS. The Order Record fields are explained below:
# Field Value or Use 1 Record type ID O
(Stands for Order type record) 2 Sequence number 1
(Only one Order per patient.) 3 LIS assigned Specimen ID
Not used. 4 Instrument assigned Specimen
ID field
User entered (may be by barcode scanner) identification or accession number of patient sample. If no ID
or sample
10 | TLA Appendix Rev. 22
name is entered a single space, (ASCII 32), will be the entry. 5 Universal Test ID and
Manufacturer's Code
^^^PREMIER HBA1C Parts 1 through 3 of the Universal Test ID are blank and thus only 3 Component
Delimiters are given for them. The last component of this field is PREMIER HBA1C, which is the
Manufacturer's Code. 6 Priority R for Routine samples and S for
Stat samples. 7 Requested / Ordered Priority Not used. 8
Specimen Collection Date &
Time
Not used.
9 Collection End Time Not used. 10 Collection Volume Not used. 11 Collector ID Not used. 12 Action
Code Q for Control samples otherwise
empty 13 Danger Code Not used. 14 Relevant Clinical Info
Not used. 15 Date / Time Specimen Received Not used. 16 Specimen Descriptor Blood type. H for
haemolysate
samples, A for anaemic samples and empty for whole blood samples. 17 Ordering Physician Not used. 18
Physician's Tel # Not used. 19 User Field #1 Not used. 20 User Field #2 Not used. 21 Lab Field #1 Not
used. 22 Lab Field #2 Not used. 23 Date/Time Results Reported Not used. 24 Instrument Charge (billing)
Not used. 25 Instrument Section ID TLA^000
TLA^001 for STAT samples only 26 Report Type F
(Stands for Final.)
The fields are separated with a defined Field Delimiter, “|”; empty or Not used fields will only contain the
Field Delimiter. The final field may or may not end with the Field Delimiter. The end of the Order Record
will
11 | TLA Appendix Rev. 22
be indicated with a Carriage Return character (ASCII 13). Any ASTM E1394-97 prescribed fields
following the Carriage Return character will not be used and therefore not sent.
The Premier HbA1c software provides 4 results for each assay. The Result Records 1 through 4 are the
actual results of the assay of each patient sample.
The Result Record 1 fields are explained below:
# Field Value or Use 1 Record type ID R
(Stands for Results type record) 2 Sequence number 1
(Test result 1 of 6.) 3 Universal Test ID and
Manufacturer's Code
^^^GHb Parts 1 through 3 of the Universal Test ID are blank and thus only 3 Component Delimiters are
given for them. The last component of this field is GHb, which is the Manufacturer's Code. 4 Data Value
--- 5 Units of data %
The percent character, (ASCII 37). 6 Reference Ranges Not used. 7
Result Abnormal Flags Not used. 8 Nature of Abnormality
Testing
Not used.
9 Status F
(Stands for Final) 10 Date of Change in
Instrument Normative Values field
Not used.
11 Operator Identification
field
Not used.
12 Date/Time Test Started
field
Not used.
13 Date/Time Test
Completed
Date and time in the format: YYYYMMDDHHMMSS 14 Instrument
Identification
Not used.
The fields are separated with a defined Field Delimiter, “|”; empty or Not used fields will only contain the
Field Delimiter. The final field may or may not end with the Field Delimiter. The end of the Results
Record will be indicated with a Carriage Return character (ASCII 13). Any ASTM E1394-97 prescribed
fields following the Carriage Return character will not be used and therefore not sent.
12 | TLA Appendix Rev. 22
The Result Record 2 fields are explained below:
# Field Value or Use 1 Record type ID R
(Stands for Results type record) 2 Sequence number 2
(Test result 2 of 6.) 3 Universal Test ID and
Manufacturer's Code
^^^HbA1c Part 1 of the Universal Test ID are blank and thus 1 Component Delimiter are given. The last
component of this field is HbA1c, which is the Manufacturer's Code. 4 Data Value Value of 0.0 through
100.0 or 0.00
through 100.00, with one or two fixed decimal places. 5 Units of data %
The percent character, (ASCII 37). 6 Reference Ranges Not
used. 7 Result Abnormal Flags Not used. 8 Nature of Abnormality Testing Not used. 9 Status F
(Stands for Final) 10 Date of Change in Instrument
Normative Values field
Not used.
11 Operator Identification field Not used. 12 Date/Time Test Started field Not used. 13 Date/Time Test
Completed Date and time in the format:
YYYYMMDDHHMMSS 14 Instrument Identification Not
used.
The fields are separated with a defined Field Delimiter, “|”; empty or Not used fields will only contain the
Field Delimiter. The end of the Results Record will be indicated with a Carriage Return character (ASCII
13). Any ASTM E1394-97 prescribed fields following the Carriage Return character will not be used and
therefore not sent.
The Result Record 3 fields are explained below (legacy reporting units of AG):
# Field Value or Use 1 Record type ID R
(Stands for Results type record)
13 | TLA Appendix Rev. 22
2 Sequence number 3
(Test result 3 of 6.) 3 Universal Test ID and
Manufacturer's Code
^^^AG Parts 1 through 3 of the Universal Test ID are blank and thus only 3 Component Delimiters are
given for them. The last component of this field is AG, which is the Manufacturer's Code. 4 Data Value
--- 5 Units of data mg/dl or mmol/l
User selectable. For milligrams per deciliter or millimoles per litre. 6 Reference Ranges Not used. 7
Result Abnormal Flags Not used. 8 Nature of Abnormality Testing Not used. 9 Status F
(Stands for Final) 10 Date of Change in Instrument
Normative Values field
Not used.
11 Operator Identification field Not used. 12 Date/Time Test Started field Not used. 13 Date/Time Test
Completed Date and time in the format:
YYYYMMDDHHMMSS 14 Instrument Identification Not
used.
The fields are separated with a defined Field Delimiter, “|”; empty or Not used fields will only contain the
Field Delimiter. The final field may or may not end with the Field Delimiter. The end of the Results
Record will be indicated with a Carriage Return character (ASCII 13). Any ASTM E1394-97 prescribed
fields following the Carriage Return character will not be used and therefore not sent.
14 | TLA Appendix Rev. 22
The Result Record 4 fields are explained below:
# Field Value or Use 1 Record type ID R
(Stands for Results type record) 2 Sequence number 4
(Test result 4 of 6.) 3 Universal Test ID and
Manufacturer's Code
^^^mMA1c Part 3 of the Universal Test ID is blank and thus a Component Delimiter is given for that
place. Components of this field is mMA1c, which is the Manufacturer's Code. 4 Data Value Value of 0.0
through 999.9, with one
fixed decimal place or no decimal places. 5 Units of data mMolHbA1c/MolHb 6 Reference Ranges Not
used. 7 Result Abnormal Flags Not used. 8 Nature of Abnormality
Testing
Not used.
9 Status F
(Stands for Final) 10 Date of Change in
Instrument Normative Values field
Not used.
11 Operator Identification field Not used. 12 Date/Time Test Started field Not used. 13 Date/Time Test
Completed Date and time in the format:
YYYYMMDDHHMMSS 14 Instrument Identification Not used.
The fields are separated with the Primus defined Field Delimiter, “|”; empty or Not used fields will only
contain the Field Delimiter. The end of the Results Record will be indicated with a Carriage Return
character (ASCII 13). Any ASTM E1394-97 prescribed fields following the Carriage Return character
will not be used and therefore not sent.
15 | TLA Appendix Rev. 22
The Result Record 5 fields are explained below (if transmitting codes is disabled, this record will be
deleted):
# Field Value or Use 1 Record type ID R
(Stands for Results type record) 2 Sequence number 5
(Test result 5 of 6.) 3 Universal Test ID and
Manufacturer's Code
^^^Code Part 3 of the Universal Test ID is blank and thus a Component Delimiter is given for that place.
Components of this field is Code, which is the Manufacturer's Code. 4 Data Value Value of 1 through 12,
more than one
code could be displayed. 5 Units of data Not used. 6 Reference
Ranges Not used. 7 Result Abnormal Flags Not used. 8 Nature of Abnormality
Testing
Not used.
9 Status F
(Stands for Final) 10 Date of Change in
Instrument Normative Values field
Not used.
11 Operator Identification field Not used. 12 Date/Time Test Started field Not used. 13 Date/Time Test
Completed Date and time in the format:
YYYYMMDDHHMMSS 14 Instrument Identification Not used.
The fields are separated with a defined Field Delimiter, “|”; empty or Not used fields will only contain the
Field Delimiter. The end of the Results Record will be indicated with a Carriage Return character (ASCII
13). Any ASTM E1394-97 prescribed fields following the Carriage Return character will not be used and
therefore not sent.
16 | TLA Appendix Rev. 22
The Result Record 6 fields are explained below (if chromatogram points is disabled, this record will be
deleted):
# Field Value or Use 1 Record type ID R
(Stands for Results type record) 2 Sequence number 6
(Test result 6 of 6.) 3 Universal Test ID and
Manufacturer's Code
^^^Data Points Part 3 of the Universal Test ID is blank and thus a Component Delimiter is given for that
place. Components of this field is Data Points, which is the Manufacturer's Code. 4 Data Value Value of
integers. Total of 60 averaged data points (sampled from all the data points) are displayed. 5 Units of data
Not used. 6 Reference Ranges Not used. 7 Result Abnormal Flags Not used. 8 Nature of Abnormality
Testing
Not used.
9 Status F
(Stands for Final) 10 Date of Change in
Instrument Normative Values field
Not used.
11 Operator Identification field Not used. 12 Date/Time Test Started field Not used. 13 Date/Time Test
Completed Date and time in the format:
YYYYMMDDHHMMSS 14 Instrument Identification Not used.
The fields are separated with a defined Field Delimiter, “|”; empty or Not used fields will only contain the
Field Delimiter. The end of the Results Record will be indicated with a Carriage Return character (ASCII
13). Any ASTM E1394-97 prescribed fields following the Carriage Return character will not be used and
therefore not sent.
17 | TLA Appendix Rev. 22
Message Terminator Record
The Message Terminator is sent once all the results have been sent to the LIS. The Message Terminator
fields are explained below:
# Field Value or Use 1 Record type ID L
(Stands for Message Terminator record) 2 Sequence number 1
The fields are separated with a defined Field Delimiter, “|”. The final field may or may not end with the
Field Delimiter. The end of the Message Terminator Record will be indicated with a Carriage Return
character (ASCII 13). Any ASTM E1394-97 prescribed fields following the Carriage Return character
will not be used and therefore not sent.
Example of ASTM E1394 Transmission between Premier and the LIS
Records Received by LIS:
RX: H|\^&|||PREMIER^XXXXXX||||||ASTM RECVR|||P| E 1394-97|20090519153949<0D> RX:
P|1<0D> RX: O|1||Jon Davis|^^^PREMIER HBA1C|R|||||||||||||||||||TLA^000|F<0D> RX:
R|1|^^^GHb|---|%||||F||||20090519153950||<0D> RX: R|2|^^^HbA1c|9.0|%||||F||||20090519153950||<0D>
RX: R|3|^^^AG|---|mg/dl||||F||||20090519153950||<0D> RX:
R|4|^^^mMA1c|73.2|mMolHbA1c/MolHb||||F||||20090519153950||<0D> RX: R|5|^^^Code|1 8 12
|||||F||||20090519153950||<0D> (if transmitting codes is disabled, this record will be deleted) RX:
R|6|^^^Data Points|1,1,-1,-3,-2,-1,-
1,0,1,39,442,3113,9440,13952,12531,8385,4742,2455,1209,632,379,257,194,158,133,
116,102,92,83,77,71,65,64,64,62,65,111,295,446,427,351,294,261,243,233,222,206,18
4,157,131,109,87,69,54,44,37,34,33,30,26 |||||F||||20090519153950||<0D> (if transmitting chromatogram
points is disabled, this record will be deleted) RX: P|2<0D> ...... ...... RX: L|1<0D> Where: RX is Premier
transmitted records (received by LIS) <0D> is a Carriage Return
18 | TLA Appendix Rev. 22
Host Query Message Format
1. Query message
This section describes the query message structure and each record.
Query message structure (Premier Instrument -> PC (LIS))
Query header record H Query Record Q Message End Record L
Query record is composed of 13 fields.
# Field Description Remark (Example) 1 Record Type Set Character “Q” 2 Sequence No. Set Digit “1” 3
Patient ID Sample ID (*1,*2,*3) “123456789012345” 13 Query Code Indicates the content of query
(Request an order)
“O”
End of record End of record <CR> (0x)D)
Example 1: Q|1|123456789012345||||||||||O<CR>
Example 2: Q|1|12345678901234567890123||||||||||O<CR>
(*1) Sample ID consists of one component only. (*2) Sample ID has no length restriction. (*3) Sample ID
is not padded with any character. The ‘|’ character should be used for splitting.
2. Response Message
Response message structure (PC (LIS) -> Premier Instrument)
Message header record H Patient information record P Test order record O Message end record L
✓ Patient information record is composed of 2 fields.
# Field Description Remark (Example) 1 Record Type Set Character “P”
19 | TLA Appendix Rev. 22
2 Sequence No. Sequence number starting with “1” “1”
End of record End of record <CR> (0x0D) Example: P|1<CR>
✓ Test Order Record
Test order record is composed of 16 fields, which are different from those of the measurement result
message.
# Field Description Remark (Example) 1 Record Type Set Character “O” 2 Sequence No. Set digit “1” 3
Patient ID Sample ID (*1,*2,*3) “123456789012345” 5 Measurement
Item
Measurement item name (either of below)
1. Measure (*4) 2. No measure
1. “^^^HbA1c” 2. NULL (No output)
6 Priority Priority Code (Routine Sample) “R” 16 Sample type Sample type (either of below)
1. Whole blood Sample (default) 2. Haemolysate Sample 3. Anemic Sample
1. NULL 2. “H” 3. “A”
End of record End of record <CR> (0x0D)
Example 1: O|1|123456789012345||^^^HbA1c|R||||||||||H<CR>
Example 2: O|1|12345678901234567890123||^^^HbA1c|R||||||||||H<CR>
(*1) Sample ID consists of one component only. (*2) Sample ID has no length restriction. (*3) Sample ID
is not padded with any character. The ‘|’ character should be used for splitting. (*4) Measurement item
consists of four components but the first three are not used.
20 | TLA Appendix Rev. 22
21 | TLA Appendix Rev. 22